Massive Spontaneous Suprachoroidal Hemorrhage in a Patient With Type 1 Chronic Myeloid Leukemia and Lymphoplasmacytic Lymphoma: Case Report and Review of the Literature

J Vitreoretin Dis. 2022 May 25;6(3):214-220. doi: 10.1177/24741264221074799. eCollection 2022 May-Jun.

Abstract

Purpose: This work reports a rare case of spontaneous suprachoroidal hemorrhage (SSCH) and summarizes the literature on its treatment options and outcomes.

Methods: A case report and comprehensive literature review are presented on the medical and surgical management of SSCH on PubMed from 1998 to 2021.

Results: The literature search revealed 58 studies, 33 of which included 52 eyes of 47 patients. Surgical treatment typically consisted of choroidal drainage with posterior sclerotomies combined with pars plana vitrectomy and silicone oil placement. Medical therapy involved intraocular pressure control with laser peripheral iridotomy and topical, oral, and intravenous medication.

Conclusions: In cases of SSCH, conservative management and a prompt workup should be initiated to identify the cause before proceeding with surgery. If the initial workup does not reveal a cause, medical and surgical treatments are both viable and the decision is at the discretion of the treating physician.

Keywords: chronic myeloid leukemia; hemorrhagic choroidal detachment; lymphoma; lymphoplasmacytic localized steroids; myeloid leukemia; ocular manifestations of lymphoma; platelets adhesion; spontaneous suprachoroidal hemorrhage.

Publication types

  • Review